San Diego, USA — March 19, 2024. Crown Bioscience, a global contract research organization (CRO) and JSR Life Sciences company, solidifies its stature as a frontrunner in the global healthcare sector by securing the T+ Employer® certification for healthcare excellence every year since the award was inaugurated in 2020.
This prestigious accolade, awarded by the Health Human Resources Development Center of the National Health Commission of China and MedTalent, highlights the company's unwavering dedication to fostering a landmark corporate culture marked by inclusivity, innovation, and a seamless customer service.
The T+ Employer® certification celebrates Crown Bioscience's impactful values and trendsetting role within the pharmaceutical, medical, life science, and virtual healthcare industries. This recognition is a testament to its pioneering leadership, which is validated through rigorous evaluation that includes enterprise research, professional public surveys, insights from key opinion leaders, and campus studies.
Company-wide initiatives such as significant contributions to oncology research and promoting cross-regional departmental collaboration via digitization and human systems have distinguished Crown Bioscience as a paradigm of employer excellence.
Shirley Huang, MBA, Senior Vice President of Human Resources, said: ‘’The reaffirmation of the T+ Employer® certification is more than an accolade, it symbolizes the commitment of our talented team and the harmony with our values. In an ever-evolving industry landscape, this award is a testament to our ongoing efforts to merge our business goals with a supportive and thriving work culture.’’
Launched by the MedTalent and Med+ Institute as the healthcare industry's inaugural employer certification, the T+ Employer® certification has become a symbol of employment distinction and a beacon for healthcare businesses aspiring to excellence.
This achievement underscores Crown Bioscience’s dedication to setting high standards and pushing the boundaries of innovation across all facets of its business. It reflects the company's strong resolve to enrich the work environment, consistently deliver beyond client expectations, and elevate industry standards.
Contact details
-
- Louise Stenson
-
Crown Bioscience Company Inquiries
Communications Manager - louise.stenson@crownbio.com
Related topics
Related news
Crown Bioscience Completes Merger with Indivumed Services
Crown Bioscience completes Indivumed Services merger, offering enhanced drug development solutions globally and retiring the Indivumed brand.
Crown Bioscience Germany GmbH Achieves Continued CAP 15189:2022 Accreditation
Crown Bioscience's Hamburg site secures continued CAP ISO 15189:2022 accreditation, showcasing its commitment to quality in laboratory services.
Crown Bioscience Wins 2024 Fierce CRO Award for Excellence in Client Service and Partnership
Crown Bioscience wins 2024 Fierce CRO Award for excellence in client service, underscoring its commitment to innovative drug development partnerships.
Crown Bioscience Wins BioTech Breakthrough Award for Drug Development Innovation
Crown Bioscience's OrganoidXplore receives BioTech Award, revolutionizing oncology with advanced preclinical screening.
Prostate Cancer Breakthrough: Crown Bioscience Collaborates in €1.75M Eurostars Funded Project for Novel Liquid Biops...
Crown Bioscience, part of JSR Life Sciences, joins a €1.75M Eurostars project to develop a novel liquid biopsy for prostate cancer, enhancing treatment.